<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04062643</url>
  </required_header>
  <id_info>
    <org_study_id>2010/101</org_study_id>
    <nct_id>NCT04062643</nct_id>
  </id_info>
  <brief_title>Obesity Effect on Stroke and Cardiovascular Events</brief_title>
  <acronym>OSR</acronym>
  <official_title>OBESITY ASSOCIATION WITH RECURRENT STROKE AND CARDIOVASCULAR EVENTS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ege University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ege University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The relation between obesity and stroke recurrence is still under debate. In this study it
      has been sought whether baseline obesity is associated with recurrent stroke and major
      cardiovascular events in a long-time period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Five-years follow-up data of Ege Stroke Registry for stroke recurrence and cardiovascular
      events regarding to obesity were analyzed. Data include age, gender, stroke severity,
      neuroimaging studies, cardiovascular risk factors. Within the inclusion period, all of the
      included patients were followed until censoring (10th of December 2011) or readmission
      because of recurrent stroke, cardiovascular event or death, whichever came first. The
      Kaplan-Meier method was used for survival analysis. Cox proportional hazard model was applied
      to identify predictors of recurrent vascular events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2000</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stroke recurrence</measure>
    <time_frame>5 years</time_frame>
    <description>Ischemic or hemorrhagic stroke</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">9285</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Patients with obesity</arm_group_label>
    <description>Obesity in those with BMI â‰¥30 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without obesity</arm_group_label>
    <description>Normal weight was considered in the patients with BMI &lt;30 kg/m2</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Obesity assessment</intervention_name>
    <description>Body mass index (BMI (kg/m2) was calculated from measurements of weight to the nearest kg and height</description>
    <arm_group_label>Patients with obesity</arm_group_label>
    <arm_group_label>Patients without obesity</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All stroke patients enrolled in the prospective cohort registry in Egeanregion.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consecutive stroke patients.

        Exclusion Criteria:

          -  Incomplete baseline information, other factors making them unsuitable for
             follow-up,undetermined stroke, subarachnoid hemorrhage.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 8, 2019</study_first_submitted>
  <study_first_submitted_qc>August 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2019</study_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ege University</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Emre Kumral</investigator_full_name>
    <investigator_title>Ege Neurology</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>recurrent stroke</keyword>
  <keyword>ischemic stroke</keyword>
  <keyword>hemorrhagic stroke</keyword>
  <keyword>cardiovascular events</keyword>
  <keyword>vascular death</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>If the publisher will accept to share IPD, we can give permission to share IPD.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

